Santos ES - Search Results

1

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2.

Gajra A, Karim NA, Mulford DA, Villaruz LC, Matrana MR, Ali HY, Santos ES, Berry T, Ong TJ, Sanford A, Amiri K, Spigel DR. Gajra A, et al. Among authors: santos es. Front Oncol. 2018 Jul 24;8:253. doi: 10.3389/fonc.2018.00253. eCollection 2018. Front Oncol. 2018. PMID: 30087850 Free PMC article.

2

Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma.

Saigal K, Santos ES, Tolba K, Kwon D, Elsayyad N, Abramowitz MC, Mandalia A, Samuels MA. Saigal K, et al. Among authors: santos es. Front Oncol. 2014 Jun 30;4:165. doi: 10.3389/fonc.2014.00165. eCollection 2014. Front Oncol. 2014. PMID: 25072020 Free PMC article.

3

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.

Owonikoko TK, Niu H, Nackaerts K, Csoszi T, Ostoros G, Mark Z, Baik C, Joy AA, Chouaid C, Jaime JC, Kolek V, Majem M, Roubec J, Santos ES, Chiang AC, Speranza G, Belani CP, Chiappori A, Patel MR, Czebe K, Byers L, Bahamon B, Li C, Sheldon-Waniga E, Kong EF, Williams M, Badola S, Shin H, Bedford L, Ecsedy JA, Bryant M, Jones S, Simmons J, Leonard EJ, Ullmann CD, Spigel DR; C14018 study investigators. Owonikoko TK, et al. Among authors: santos es. J Thorac Oncol. 2020 Feb;15(2):274-287. doi: 10.1016/j.jtho.2019.10.013. Epub 2019 Oct 23. J Thorac Oncol. 2020. PMID: 31655296 Free article. Clinical Trial.

4

Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.

Santos ES, Kaplan B, Kirshner E, Croft EF, Sequist LV, Chau M, Munley J, Oxnard GR. Santos ES, et al. Oncol Ther. 2018 Jun;6(1):45-58. doi: 10.1007/s40487-018-0061-y. Epub 2018 May 25. Oncol Ther. 2018. PMID: 32700141 Free PMC article.

5

Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer.

Velez M, Arango BA, Perez CA, Santos ES. Velez M, et al. Among authors: santos es. Clin Med Insights Oncol. 2012;6:117-24. doi: 10.4137/CMO.S6248. Epub 2012 Feb 20. Clin Med Insights Oncol. 2012. PMID: 22412303 Free PMC article.

6

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib.

Corrales L, Nogueira A, Passiglia F, Listi A, Caglevic C, Giallombardo M, Raez L, Santos E, Rolfo C. Corrales L, et al. Front Med (Lausanne). 2017 Feb 28;4:13. doi: 10.3389/fmed.2017.00013. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28293555 Free PMC article. Review.

7

Tumor Type-Agnostic Treatment and the Future of Cancer Therapy.

Raez LE, Santos ES. Raez LE, et al. Among authors: santos es. Target Oncol. 2018 Oct;13(5):541-544. doi: 10.1007/s11523-018-0593-y. Target Oncol. 2018. PMID: 30302723 No abstract available.

8

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.

Schneider BJ, Ismaila N, Aerts J, Chiles C, Daly ME, Detterbeck FC, Hearn JWD, Katz SI, Leighl NB, Levy B, Meyers B, Murgu S, Nekhlyudov L, Santos ES, Singh N, Tashbar J, Yankelevitz D, Altorki N. Schneider BJ, et al. Among authors: santos es. J Clin Oncol. 2020 Mar 1;38(7):753-766. doi: 10.1200/JCO.19.02748. Epub 2019 Dec 12. J Clin Oncol. 2020. PMID: 31829901

9

Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer.

Bastos BR, Hatoum GF, Walker GR, Tolba K, Takita C, Gomez J, Santos ES, Lopes G, Raez LE. Bastos BR, et al. Among authors: santos es. J Thorac Oncol. 2010 Apr;5(4):533-9. doi: 10.1097/JTO.0b013e3181ce3e00. J Thorac Oncol. 2010. PMID: 20357618 Free article. Clinical Trial.

10

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).

Raez LE, Santos ES, Webb RT, Wade J, Brito RA, Karr M, Kennah A, Childs BH. Raez LE, et al. Among authors: santos es. Cancer Chemother Pharmacol. 2013 Nov;72(5):1103-10. doi: 10.1007/s00280-013-2301-z. Epub 2013 Sep 22. Cancer Chemother Pharmacol. 2013. PMID: 24057043 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

334 results

Search Page